comparemela.com

Latest Breaking News On - Prnewswire freenome - Page 1 : comparemela.com

Freenome Initiates PROACT LUNG Clinical Study for the Early Detection of Lung Cancer Using Blood Test Developed on Multiomics Platform

/PRNewswire/ Freenome, a privately held company developing multiomics blood tests for early cancer detection, today announced the initiation of its PROACT.

United-states
South-san-francisco
California
Americans
American
Lance-baldo
Prnewswire-freenome
Siemens-healthineers
Merck-kga
Drug-administration
Oncimmune-ltd
United-states-preventive-services-task

FREENOME ACQUIRES GLOBAL IMMUNODIAGNOSTICS DEVELOPER ONCIMMUNE LTD

– Acquisition enhances Freenome s product portfolio, including autoantibody platform with additional biomarkers important in cancer detection– Fre.

Nottingham
United-kingdom
South-san-francisco
California
United-states
Germany
Scotland
Adamm-hill
Mike-nolan
Prnewswire-freenome
Earlycdt-lung-is-oncimmune-ltd
Oncimmune-ltd

FREENOME PRESENTS RESEARCH HIGHLIGHTING THE PROMISE OF IDENTIFYING DRUG-RESPONSE BIOMARKERS FOR DLBCL PATIENTS

– Freenome s comprehensive multiomics and multi-feature computational approach provides insights for therapy development and patient efficacySOUTH.

San-francisco-bay
California
United-states
New-jersey
South-san-francisco
Switzerland
London
City-of
United-kingdom
American
Mike-nolan
Patrick-van-berkel

FREENOME AND MERCK KGAA, DARMSTADT, GERMANY TO PRESENT DATA ON COMBINATION OF MULTIOMICS PROFILING AND COMPUTATIONAL MODELING AT AACR ANNUAL MEETING

FREENOME AND MERCK KGAA, DARMSTADT, GERMANY TO PRESENT DATA ON COMBINATION OF MULTIOMICS PROFILING AND COMPUTATIONAL MODELING AT AACR ANNUAL MEETING - read this article along with other careers information, tips and advice on BioSpace

Germany
California
United-states
Canada
South-san-francisco
American
Mike-nolan
Prnewswire-freenome
American-association-for-cancer-research
Merck-kga
Merck-kgaa
Freenome-holdings-inc

FREENOME PRESENTS RESEARCH THAT HIGHLIGHTS THE SIGNIFICANCE OF DETECTING ADENOMAS IN ANY TEST THAT SCREENS FOR COLORECTAL CANCER

/PRNewswire/ Freenome, a privately held biotech company, will present research at the American Association for Cancer Research (AACR) Annual Meeting that.

California
United-states
South-san-francisco
American
Prnewswire-freenome
Girish-putcha
American-association-for-cancer-research
Freenome-inc
American-association
Cancer-research
Annual-meeting
Freenome

vimarsana © 2020. All Rights Reserved.